Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Conditions

Subcategories:Axial SpondyloarthritisGout and Crystalline ArthritisGuidelinesMyositisOsteoarthritis and Bone DisordersOther Rheumatic ConditionsPain SyndromesPediatric ConditionsPsoriatic ArthritisRheumatoid ArthritisSjögren’s DiseaseSoft Tissue PainSystemic Lupus ErythematosusSystemic SclerosisVasculitis

Letters to the Editor

Staff  |  February 12, 2011

Feedback from our Readers

Expression of CD154 Protein Linked to Increased Risk for Developing RA

Staff  |  February 12, 2011

An ongoing study of key immune system proteins has pinpointed an area associated with increased risk for inflammatory disease and may one day lead to new therapies to control inflammation and rheumatic diseases.

New Approaches to Inflammatory Myopathy

Vanessa Caceres  |  February 12, 2011

Advances in diagnostic modalities and treatments emerge

Is an Onslaught of Pain on the Horizon?

Vanessa Caceres  |  February 12, 2011

Pain treatment varies based on race and gender, and many patients don’t receive optimal care

Family, Fatigue & Heart Health

Richard Sine  |  February 12, 2011

Researchers explore several factors in the health and well-being of patients with lupus

Chronotherapy with Glucorticoids in Rheumatoid Arthritis

Frank Buttgereit, MD  |  January 17, 2011

Time is of the essence in balancing risks and benefits

Phoning It In

Bruce N. Cronstein, MD  |  January 17, 2011

The missed message on methotrexate

A Review of Wegener’s Treatment Data

Vanessa Caceres  |  January 17, 2011

Clinical trials show changing role of existing treatment and introduction of newer medications

Treat JIA Without Slowing Growth

By Sue Pondrom  |  January 4, 2011

Etanercept does not impede normal height and weight development in these patients

Macrophage Activation Syndrome

Alexei A. Grom, MD  |  December 1, 2010

A review of diagnosis, treatment, and prognosis

  • « Previous Page
  • 1
  • …
  • 312
  • 313
  • 314
  • 315
  • 316
  • …
  • 339
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences